Besides, increased histone acetylation has been observed in prostate cancer cells that over-express CPT1A, suggesting that acetylation may be a means by which CPT1A controls prostate cancer cell proliferation (Joshi et al., 2019). The gene discussed is CPT1A; the disease is prostate carcinoma.